BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris™ Infusion System
Learn More-
Innovation at BD
The Future and InnovationDiscover how we’re innovating to drive better outcomes for patients at critical moments throughout their livesLearn more
-
NEWS
BD Initiates Study to Further Advance the Treatment of Portal HypertensionLearn MoreFirst patient enrollment in ARCH study begins investigation of the safety and effectiveness of the BD Liverty™ Transjugular Intrahepatic Portosystemic Shunt (TIPS) Stent Graft to reduce...
-
NEWS
Bill & Melinda Gates Foundation, Children’s Investment Fund Foundation, Pfizer and Becton, Dickinson & Company Expand Partnership for Greater Access to Injectable Contraceptive for Women in Low- and Lower-Middle-Income CountriesLearn MoreIncreased manufacturing capacity combined with an expansion from 69 to 92 eligible countries, is expected to enable delivery of more than 320 million doses through 2030 Previously guaranteed...
-
News
Patterns of Bacterial ResistanceListen as BD thought leaders Dr. Gupta and Dr. Yu give insights into patterns of rising bacterial resistance at a Health Watch USA Meeting on May 19, 2022Learn more